SALES FORECAST: Novartis's sales are forecast at $12.78 billion, according to analysts' estimates compiled by Visible Alpha. This compares with $11.42 billion the year before. Shares rose 5.1% over ...
LeukemiaANT308 has shown strong single-agent anti-leukemia activity in 2 mouse models. (2) Pancreatic cancerANT308 has shown synergistic effects with anti-PD-1 checkpoint inhibitors in 3 pancreatic ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...
Yes, it is possible to develop an iron deficiency without experiencing anemia. Health experts may refer to this as nonanemic iron deficiency or iron deficiency without anemia. Although iron ...